Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

SELL
$0.96 - $2.92 $44,743 - $136,095
-46,608 Reduced 66.56%
23,416 $29,000
Q4 2022

Feb 14, 2023

BUY
$1.74 - $12.87 $1,350 - $9,987
776 Added 1.12%
70,024 $151,000
Q3 2022

Nov 18, 2022

BUY
$7.21 - $14.88 $20,707 - $42,735
2,872 Added 4.33%
69,248 $830,000
Q2 2022

Aug 15, 2022

SELL
$5.97 - $9.97 $17,396 - $29,052
-2,914 Reduced 4.21%
66,376 $556,000
Q1 2022

May 16, 2022

SELL
$8.44 - $12.49 $54,986 - $81,372
-6,515 Reduced 8.59%
69,290 $601,000
Q4 2021

Feb 15, 2022

BUY
$10.12 - $14.07 $17,335 - $24,101
1,713 Added 2.31%
75,805 $857,000
Q3 2021

Nov 15, 2021

SELL
$7.25 - $13.23 $85,049 - $155,201
-11,731 Reduced 13.67%
74,092 $931,000
Q2 2021

Aug 16, 2021

BUY
$8.0 - $9.75 $3,072 - $3,744
384 Added 0.45%
85,823 $697,000
Q1 2021

May 18, 2021

SELL
$8.63 - $10.94 $2,658 - $3,369
-308 Reduced 0.36%
85,439 $790,000
Q3 2020

Nov 17, 2020

BUY
$11.3 - $14.75 $124,300 - $162,250
11,000 Added 14.72%
85,747 $1.06 Million
Q2 2020

Aug 17, 2020

BUY
$9.52 - $15.98 $84,109 - $141,183
8,835 Added 13.4%
74,747 $972,000
Q1 2020

May 13, 2020

BUY
$8.0 - $15.48 $6,104 - $11,811
763 Added 1.17%
65,912 $669,000
Q4 2019

Feb 14, 2020

SELL
$14.82 - $26.79 $24,808 - $44,846
-1,674 Reduced 2.51%
65,149 $1.02 Million
Q3 2019

Nov 15, 2019

BUY
$16.02 - $22.47 $577,056 - $809,391
36,021 Added 116.94%
66,823 $1.12 Million
Q2 2019

Aug 14, 2019

BUY
$16.12 - $22.89 $219,248 - $311,326
13,601 Added 79.07%
30,802 $683,000
Q1 2019

May 09, 2019

BUY
$17.58 - $23.97 $302,393 - $412,307
17,201 New
17,201 $373,000

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $80.8M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.